Cholesta-5,7-dien-3beta-ol (7,8-Didehydrocholesterol, Provitamin D3)

cas: 434-16-2 — see every product listed under this CAS number, including other names

Cholesta-5,7-dien-3beta-ol (7,8-Didehydrocholesterol, Provitamin D3) (CAS 434-16-2) is a chemical reagent available from Chemat. Available pack sizes: 25mg, 100mg. Offered by: Mikromol.

• 2D
• 3D

Cholesta-5,7-dien-3beta-ol is a Delta(5),Delta(7)-sterol, a 3beta-hydroxy-Delta(5)-steroid, a 3beta-sterol and a cholestanoid. It has a role as a mouse metabolite and a human metabolite.

Source: ChEBI

Identity

Molecular formula	C27H44O
Molecular weight	384.6 g/mol
IUPAC name	(3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKey	UCTLRSWJYQTBFZ-DDPQNLDTSA-N
SMILES	C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C

Computed by PubChem (NCBI)

Synonyms: 7-Dehydrocholesterol, Provitamin D3, Cholesta-5,7-dien-3beta-ol, 7,8-Didehydrocholesterol, (3beta)-Cholesta-5,7-dien-3-ol, 5,7-Cholestadien-3-beta-ol, cholesta-5,7-dien-3 beta-ol, Cholesta-5,7-dien-3-ol, (3beta)-, provitamin D(3), Dehydrocholesterol

Related forms of this compound

(3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

(3S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

(3S,9S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

Isomers (same molecular formula)

(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C₂₇H₄₄O

(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-7,7,7-trideuterio-6-(trideuteriomethyl)hept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C₂₇H₄₄O

(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

(1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C₂₇H₄₄O

(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C₂₇H₄₄O

(1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C₂₇H₄₄O

(1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C₂₇H₄₄O